Search
Search Results
##search.searchResults.foundPlural##
-
APPROPRIATE DURATION OF INTRAVENOUS TREATMENT OF CANDIDEMIA AND TIMING OF STEP DOWN TO ORAL THERAPY IN NON-NEUTROPENIC PATIENTS
2884PDF: 1075HTML: 365Preferred Reviewers: 209 -
AUTOLOGOUS STEM CELL TRANSPLANTATION FOR AGGRESSIVE LYMPHOMAS
2559PDF: 873HTML: 2124 -
As a Rare Site of Invasive Fungal Infection, Chronic Granulomatous Aspergillus Synovitis: A Case Report
1722PDF: 627HTML: 1518Figure 1: MRI demonstrating Aspergillus synovitis: 185Figure 2:MRI demonstrating Aspergillus synovitis: 191 -
WHAT ARE FUNGAL INFECTIONS?
4202PDF: 2390HTML: 27617de Pauw: 239 -
EXTREMELY OLD PATIENTS HOSPITALIZED IN INTERNAL MEDICINE: WHAT ABOUT THEIR ANEMIA? Anemia in the elderly
1602PDF: 506HTML: 237 -
ASSESSMENT OF THE EFFICACY OF PROCALCITONIN, C-REACTIVE PROTEIN AND ALBUMIN LEVELS-GUIDED ANTIBIOTICS USE IN SEPSIS
949PDF: 511Html: 146Suppl. Files: 175 -
EPIDEMIOLOGY OF MALARIA IN ENDEMIC AREAS
5326PDF: 2653HTML: 49582 -
DIAGNOSIS OF MALARIA INFECTION WITH OR WITHOUT DISEASE
3625PDF: 1111HTML: 23339 -
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
7997PDF: 4178HTML: 7476 -
IMPACT OF QUALITATIVE AND QUANTITATIVE IMMUNOPARESIS ON EARLY INFECTION RISK IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA Immunoparesis and early infection risk in myeloma
30PDF: 16HTML: 1 -
Ceftolozane-Tazobatam for febrile neutropenia treatment in hematologic malignancy patients colonized by multi-resistant Enterobacteriaceae: preliminary results from a prospective cohort study Ceftolozane-Tazobatam for febrile neutropenia
7860PDF: 725HTML: 220 -
PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
3702PDF: 1240HTML: 3902Untitled: 216Untitled: 262 -
HODGKIN LYMPHOMA IN OLDER PATIENTS: AN ORPHAN DISEASE?
2892PDF: 1366HTML: 3571Untitled: 194Untitled: 207Untitled: 180 -
SHORT HISTORY OF MALARIA AND ITS ERADICATION IN ITALY
4855PDF: 1904HTML: 11148Fig 1: 224Fig 2: 185Fig 3: 302Fig 4: 189Fig 5: 182Fig 6: 177Fig 7: 193Fig 8: 184 -
LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML
1739PDF: 1172HTML: 249 -
SIMPLE PERIPHERAL BLOOD SMEAR FINDINGS OF COVID-19 PATIENTS PROVIDE INFORMATION ABOUT THE SEVERITY OF THE DISEASE AND THE DURATION OF HOSPITAL STAY. Peripheral blood smear and COVID-19 severity.
3302PDF: 1115HTML: 447 -
DEMOGRAPHICAL, VIRO-IMMUNOLOGICAL, CLINICAL AND THERAPEUTICAL CHARACTERISTICS OF HIV INFECTED PATIENTS IN A “EPIDEMIOLOGICALLY UNEXPLORED” REGION OF ITALY (CALABRIA REGION): THE CALABRHIV COHORT.
1605PDF: 803HTML: 1237Figure 1: 174Figure 2: 191Figure 3: 186 -
PROCALCITONIN AS A BIOMARKER OF BACTERIAL INFECTION IN SICKLE CELL VASO-OCCLUSIVE CRISIS.
2074PDF: 1049HTML: 15655COVER LETTER: 191 -
CHRONIC MYELOGENOUS LEUKEMIA (CML) IN THE ELDERLY
2891PDF: 1102HTML: 3034 -
ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
4330PDF: 1379HTML: 2046 -
The COVID-19 in Omani children with chronic Hemato-oncology diseases COVID-19 in Omani children with chronic Hemato-oncology diseases
889PDF: 687HTML: 323







